Reproducibility of quantitative (R)-[11C]verapamil studies
Open Access
- 1 January 2012
- journal article
- Published by Springer Science and Business Media LLC in EJNMMI Research
- Vol. 2 (1), 1
- https://doi.org/10.1186/2191-219x-2-1
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PETEuropean Journal of Clinical Pharmacology, 2009
- Imaging the Function of P-Glycoprotein With Radiotracers: Pharmacokinetics and In Vivo ApplicationsClinical Pharmacology & Therapeutics, 2009
- Blood–brain barrier P-glycoprotein function is not impaired in early Parkinson's diseaseParkinsonism & Related Disorders, 2008
- Partial volume corrected image derived input functions for dynamic PET brain studies: Methodology and validation for [11C]flumazenilNeuroImage, 2008
- Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt–Jakob diseaseActa Neuropathologica, 2006
- MR-based automatic delineation of volumes of interest in human brain PET images using probability mapsNeuroImage, 2005
- Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood–brain barrier: kinetics and metabolism in the ratNuclear Medicine and Biology, 2005
- Potential role of ABC transporters as a detoxification system at the blood–CSF barrierAdvanced Drug Delivery Reviews, 2004
- Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PETEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- Statistical methods for assessing agreement between two methods of clinical measurement.1986